NYSE - Delayed Quote USD

Chemed Corporation (CHE)

560.42 -12.92 (-2.25%)
At close: April 26 at 4:00 PM EDT
559.74 -0.68 (-0.12%)
After hours: April 26 at 5:29 PM EDT
Key Events
Loading Chart for CHE
DELL
  • Previous Close 573.34
  • Open 570.22
  • Bid 224.60 x 900
  • Ask 659.00 x 800
  • Day's Range 557.90 - 577.17
  • 52 Week Range 492.84 - 654.62
  • Volume 102,418
  • Avg. Volume 83,833
  • Market Cap (intraday) 8.483B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 30.11
  • EPS (TTM) 18.61
  • Earnings Date Jul 24, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 1.60 (0.29%)
  • Ex-Dividend Date Feb 23, 2024
  • 1y Target Est 690.00

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

www.chemed.com

15,087

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHE

Performance Overview: CHE

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CHE
4.10%
S&P 500
6.92%

1-Year Return

CHE
0.59%
S&P 500
25.26%

3-Year Return

CHE
20.86%
S&P 500
22.00%

5-Year Return

CHE
74.40%
S&P 500
74.29%

Compare To: CHE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHE

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    8.48B

  • Enterprise Value

    8.32B

  • Trailing P/E

    30.15

  • Forward P/E

    23.81

  • PEG Ratio (5yr expected)

    2.38

  • Price/Sales (ttm)

    3.73

  • Price/Book (mrq)

    7.17

  • Enterprise Value/Revenue

    3.63

  • Enterprise Value/EBITDA

    19.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.36%

  • Return on Assets (ttm)

    13.55%

  • Return on Equity (ttm)

    27.47%

  • Revenue (ttm)

    2.29B

  • Net Income Avi to Common (ttm)

    283.4M

  • Diluted EPS (ttm)

    18.61

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    313.35M

  • Total Debt/Equity (mrq)

    12.35%

  • Levered Free Cash Flow (ttm)

    252.01M

Research Analysis: CHE

Analyst Price Targets

650.00
690.00 Average
560.42 Current
712.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CHE

Fair Value

560.42 Current
 

Dividend Score

0 Low
CHE
Sector Avg.
100 High
 

Hiring Score

0 Low
CHE
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CHE
Sector Avg.
100 High
 

Research Reports: CHE

  • CHE: Raising target price to $647.00

    CHEMED CORP has an Investment Rating of HOLD; a target price of $647.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CHE: Lowering target price to $640.00

    CHEMED CORP has an Investment Rating of HOLD; a target price of $640.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CHE: Lowering target price to $656.00

    CHEMED CORP has an Investment Rating of HOLD; a target price of $656.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CHE: Lowering target price to $669.00

    CHEMED CORP has an Investment Rating of HOLD; a target price of $669.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch